CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352528215
- Phone
- (786) 459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 50,000 shares at $0.95 ($47,275)
- 4 Open-market buy Director bought 20,000 shares at $0.97 ($19,310)
- 4 Open-market buy Director bought 65,000 shares at an average $0.97 ($63,202)
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 4,000 shares at an average $0.99 ($3,975)
- 4 Open-market buy Director bought 20,000 shares at $0.94 ($18,812)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 359,713 shares (grant or award)
- 4 Grant or award Director acquired 359,713 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Co-CEO and CFO acquired 3,598 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 424B3 Offering Prospectus
Page 3 of 34 · 673 filings